IRWD Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio5.68Forward 12.33
EPS (TTM)$0.621047.0% YoY
Profit margin28.3%HEALTHCARE
Market cap$579.4MSmall cap
Valuation
- Forward P/E
- 12.33
- PEG ratio
- -0.26
- P/B
- 2.59
- P/S (TTM)
- 1.60
- EV/EBITDA
- 4.62
Profitability & growth
- ROE (TTM)
- -575.0%
- Operating margin
- 68.1%
- Revenue growth YoY
- 158.9%
- Dividend yield
- —
- Beta
- 0.24
Last earnings
May 7, 2026 · Estimate $0.24 · Reported $0.24
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Ironwood Pharmaceuticals Inc
Company profileIronwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts.
Classification
- Sector
- Healthcare
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 100 SUMMER STREET, BOSTON, MA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$579.4M
Shares outstanding$164.6M
52W high$5.78
52W low$0.66
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent